Published in N Engl J Med on March 31, 2008
Unprotected left main revascularization in patients with acute coronary syndromes. Eur Heart J (2009) 1.66
Different treatment options in chronic coronary artery disease: when is it the time for medical treatment, percutaneous coronary intervention or aortocoronary bypass surgery? Dtsch Arztebl Int (2009) 1.18
Drug-eluting versus bare-metal stents in unprotected left main coronary artery stenosis a meta-analysis. JACC Cardiovasc Interv (2010) 1.05
Coronary ostial stenosis after aortic valve replacement: successful treatment of 2 patients with drug-eluting stents. Tex Heart Inst J (2010) 1.03
Korean guidelines for the appropriate use of cardiac CT. Korean J Radiol (2015) 0.96
The impact of generic clopidogrel bisulfate on platelet inhibition in patients with coronary artery stents: results of the ACCEL-GENERIC study. Korean J Intern Med (2010) 0.87
Stenting of complex lesions: an overview. Nat Rev Cardiol (2010) 0.87
Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores. Antimicrob Agents Chemother (2012) 0.87
Hotline update of clinical trials and registries presented at the ACC and SCAI-ACCi2 meeting 2008 in Chicago. Clin Res Cardiol (2008) 0.80
Comparison of the efficacy of drug-eluting stents versus bare-metal stents for the treatment of left main coronary artery disease. Chin Med J (Engl) (2015) 0.80
Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting. Clin Res Cardiol (2012) 0.79
Pentraxin 3 Is Highly Specific for Predicting Anatomical Complexity of Coronary Artery Stenosis as Determined by the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery Score. Korean Circ J (2014) 0.79
Clinical outcome and quality of life after interventional treatment of left main disease with drug-eluting-stents in comparison to CABG in elderly and younger patients. Clin Res Cardiol (2010) 0.79
Comparison of Bare-Metal Stent and Drug-Eluting Stent for the Treatment of Patients Undergoing Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Disease - Long-Term Result from a Single Center Experience. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2015) 0.78
Percutaneous coronary intervention for unprotected left main coronary artery stenosis. World J Cardiol (2010) 0.78
Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial. Clin Res Cardiol (2016) 0.78
Early outcome of Coronary Artery Bypass Graft Surgery in patients with significant Left Main Stem stenosis at a tertiary cardiac care center. Pak J Med Sci (2015) 0.77
Comparison of bypass surgery with drug-eluting stents in diabetic patients with left main coronary stenosis. Yonsei Med J (2011) 0.76
Combining dynamic and ECG-gated ⁸²Rb-PET for practical implementation in the clinic. Nucl Med Commun (2012) 0.75
Bilateral coronary ostial lesions in cardiovascular syphilis treated by means of percutaneous coronary stenting. Tex Heart Inst J (2013) 0.75
Stents versus bypass grafting for left main coronary artery disease. N Engl J Med (2008) 0.75
Acute myocardial infarction due to left main coronary artery disease in men and women: does ST-segment elevation matter? Arch Med Sci (2015) 0.75
Stents versus bypass grafting for left main coronary artery disease. N Engl J Med (2008) 0.75
Revascularization for unprotected left main coronary artery disease: an evolution in clinical decision making. Curr Cardiol Rep (2011) 0.75
Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with second-generation drug-eluting stents for patients with multivessel and unprotected left main coronary artery disease. SAGE Open Med (2017) 0.75
Comparison of coronary artery bypass grafting with percutaneous coronary intervention for unprotected left main coronary artery disease. Yonsei Med J (2012) 0.75
Clinical comparison of percutaneous coronary intervention with domestic drug-eluting stents versus off pump coronary artery bypass grafting in unprotected left main coronary artery disease. Int J Clin Exp Med (2015) 0.75
Unprotected left main percutaneous coronary intervention: integrated use of fractional flow reserve and intravascular ultrasound. J Am Heart Assoc (2012) 0.75
Impact of SYNTAX score on 1-year clinical outcomes in patients undergoing percutaneous coronary intervention for unprotected left main coronary artery. Am J Cardiovasc Dis (2012) 0.75
Left main PCI: An observational analysis from large single-centre experience. Indian Heart J (2015) 0.75
Stenting versus bypass surgery for the treatment of left main coronary artery disease. Yonsei Med J (2009) 0.75
Stenting or bypass surgery for unprotected left main coronary artery disease-still a long rally to go. J Thorac Dis (2016) 0.75
Stenting of left main coronary artery stenosis: A to Z. Heart Asia (2013) 0.75
Palliative combined percutaneous balloon aortic valvuloplasty and unprotected left main stenting in end stage renal disease. Curr Cardiol Rev (2010) 0.75
Percutaneous intervention vs. coronary-artery bypass grafting in left main coronary disease. N Engl J Med (2008) 0.75
Why coronary artery bypass surgery is still the optimal treatment strategy for left main stem disease: an evidence-based review with a Malaysian surgical perspective. Heart Asia (2011) 0.75
Percutaneous intervention versus coronary artery bypass graft surgery in left main coronary artery stenosis: a systematic review and meta-analysis. BMC Med (2017) 0.75
Stents versus bypass grafting for left main coronary artery disease. N Engl J Med (2008) 0.75
Left main coronary artery compression in a young woman with Eisenmenger syndrome. Heart Asia (2011) 0.75
One-stent versus two-stent techniques for distal unprotected left main coronary artery bifurcation lesions. Int J Clin Exp Med (2015) 0.75
Stents versus bypass grafting for left main coronary artery disease. N Engl J Med (2008) 0.75
[Left main intervention: options and limitations in interventional cardiology]. Herz (2011) 0.75
Early surgery versus conventional treatment for infective endocarditis. N Engl J Med (2012) 8.14
Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59
Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA (2012) 6.96
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet (2007) 6.77
Duration of dual antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med (2010) 6.37
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol (2002) 4.94
Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol (2003) 4.35
Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med (2015) 4.27
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet (2012) 4.02
Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med (2011) 3.55
Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation (2005) 3.54
In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol (2013) 3.43
Long-term outcome of percutaneous coronary intervention for chronic total occlusions. JACC Cardiovasc Interv (2011) 3.38
Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv (2009) 3.36
Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol (2007) 3.05
Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med (2014) 2.90
Extracorporeal cardiopulmonary resuscitation in patients with inhospital cardiac arrest: A comparison with conventional cardiopulmonary resuscitation. Crit Care Med (2011) 2.77
Percutaneous coronary intervention for nonculprit vessels in cardiogenic shock complicating ST-segment elevation acute myocardial infarction. Crit Care Med (2014) 2.70
Improvement of arterial stiffness in the transition from acute decompensated heart failure to chronic compensated heart failure. Clin Cardiol (2013) 2.67
Intracoronary transluminal attenuation gradient in coronary CT angiography for determining coronary artery stenosis. JACC Cardiovasc Imaging (2011) 2.60
Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial. Circulation (2013) 2.55
The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. J Biol Chem (2003) 2.51
Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation (2011) 2.46
Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation (2009) 2.42
Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study. Circulation (2011) 2.40
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation (2009) 2.40
Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nat Neurosci (2006) 2.36
Undernutrition as a predictor of poor clinical outcomes in acute ischemic stroke patients. Arch Neurol (2008) 2.36
Validation of intravascular ultrasound-derived parameters with fractional flow reserve for assessment of coronary stenosis severity. Circ Cardiovasc Interv (2011) 2.35
Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol (2006) 2.33
The clopidogrel resistance can be attenuated with triple antiplatelet therapy in patients undergoing drug-eluting stents implantation. Int J Cardiol (2008) 2.31
A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). J Am Coll Cardiol (2012) 2.28
Stroke risk after coronary artery bypass graft surgery and extent of cerebral artery atherosclerosis. J Am Coll Cardiol (2011) 2.23